Xintrum Pharmaceuticals, Ltd.
Records under this name other than patents Xintrum Pharmaceuticals, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Xintrum Pharmaceuticals, Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,220,525 | Method for dynamically removing recombinant human nerve growth factor precursor by hydrophobic interaction chromatography Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,299,548 | Gene combination capable of high-efficiency expression of recombinant human nerve growth factor Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,443,082 | Concentration gradient test reagent kit and testing method for use in bacterial/fungal drug susceptibility testing Lapsed on the fee record Ended Oct 15, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 15, 2023 | USPTO record |